Search Results - "Almansour, Nahlah Makki"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Cheminformatics and biomolecular dynamics studies towards the discovery of anti-staphylococcal nuclease domain-containing 1 (SND1) inhibitors to treat metastatic breast cancer by Makki Almansour, Nahlah

    Published in Saudi pharmaceutical journal (01-10-2023)
    “…Metastatic breast cancer is a prime health concern and leading health burden across the globe. Previous efforts have shown that protein–protein interaction…”
    Get full text
    Journal Article
  2. 2

    Triple-Negative Breast Cancer: A Brief Review About Epidemiology, Risk Factors, Signaling Pathways, Treatment and Role of Artificial Intelligence by Almansour, Nahlah Makki

    Published in Frontiers in molecular biosciences (25-01-2022)
    “…Triple-negative breast cancer (TNBC) is a kind of breast cancer that lacks estrogen, progesterone, and human epidermal growth factor receptor 2. This cancer is…”
    Get full text
    Journal Article
  3. 3

    Repurposing potential of posaconazole and grazoprevir as inhibitors of SARS-CoV-2 helicase by Abidi, Syed Hani, Almansour, Nahlah Makki, Amerzhanov, Daulet, Allemailem, Khaled S., Rafaqat, Wardah, Ibrahim, Mahmoud A. A., la Fleur, Philip, Lukac, Martin, Ali, Syed

    Published in Scientific reports (13-05-2021)
    “…As the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic engulfs millions worldwide, the quest for vaccines or drugs against the virus…”
    Get full text
    Journal Article
  4. 4

    Immunoinformatics- and Bioinformatics-Assisted Computational Designing of a Novel Multiepitopes Vaccine Against Cancer-Causing Merkel Cell Polyomavirus by Almansour, Nahlah Makki

    Published in Frontiers in microbiology (28-06-2022)
    “…Merkel cell polyomavirus (MCV) contains double-stranded DNA as its genome and is the fifth polyomavirus that infects humans. The virus causes Merkel cell…”
    Get full text
    Journal Article
  5. 5

    Computational exploration of maternal embryonic leucine zipper kinase (MELK) as a cancer drug target by Makki Almansour, Nahlah

    Published in Saudi journal of biological sciences (01-07-2022)
    “…Maternal embryonic leucine zipper kinase (MELK) is of vital importance due to its significant role in cancer development and its association with poor…”
    Get full text
    Journal Article
  6. 6

    Single nucleotide polymorphisms (SNPs) in prostate cancer: its implications in diagnostics and therapeutics by Allemailem, Khaled S, Almatroudi, Ahmad, Alrumaihi, Faris, Makki Almansour, Nahlah, Aldakheel, Fahad M, Rather, Rafiq Ahmad, Afroze, Dil, Rah, Bilal

    Published in American journal of translational research (01-01-2021)
    “…Prostate cancer is one of the most frequently diagnosed malignancies in developed countries and approximately 248,530 new cases of prostate cancer are likely…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Prospective Drug Candidates as Human Multidrug Transporter ABCG2 Inhibitors: an In Silico Drug Discovery Study by Ibrahim, Mahmoud A. A., Badr, Esraa A. A., Abdelrahman, Alaa H. M., Almansour, Nahlah Makki, Shawky, Ahmed M., Mekhemer, Gamal A. H., Alrumaihi, Faris, Moustafa, Mahmoud F., Atia, Mohamed A. M.

    Published in Cell biochemistry and biophysics (01-06-2021)
    “…Breast cancer resistance protein (ABCG2) is a human ATP-binding cassette (ABC) that plays a paramount role in multidrug resistance (MDR) in cancer therapy. The…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Identification of promising inhibitors against breast cancer disease by targeting NUDIX hydrolase 5 (NUDT5) biomolecule by Almansour, Nahlah Makki

    “…It is well documented that NUDT5 enzyme inhibition in breast cancer cell lines arrest cancer cells growth, invasiveness and migration. The NUDT5 enzyme…”
    Get full text
    Journal Article
  16. 16

    In silico drug repurposing and lipid bilayer molecular dynamics puzzled out potential breast cancer resistance protein (BCRP/ABCG2) inhibitors by Almansour, Nahlah Makki, Abdelrahman, Alaa H. M., Ismail Fagiree, Ekram, Ibrahim, Mahmoud A. A.

    “…Multidrug resistance (MDR) is a fundamental reason for the fiasco of carcinoma chemotherapy. A wide variety of anticarcinoma drugs are expelled from neoplasm…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Venetoclax analogs as promising anticancer therapeutics via targeting Bcl-2 protein: in-silico drug discovery study by Almansour, Nahlah Makki, Allemailem, Khaled S, Abd El Aty, Abeer Abas, Boussoufa, Dhouha, Ismail Fagiree, Ekram, Ibrahim, Mahmoud A A

    “…B-cell lymphoma 2 (Bcl-2) protein plays a vital role in enhancing malignant cell survival by alleviating programmed cell death. Therefore, Bcl-2 protein has…”
    Get full text
    Journal Article